Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Reporter.
Press releases published on May 28, 2025
Milestone Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
MONTREAL AND CHARLOTTE, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that Amit Hasija, Chief Financial Officer, and Lorenz Muller, Chief Commercial Officer, will present at the Jefferies Healthcare …
Cocrystal Pharma to Participate in Noble Capital Markets’ 2025 Emerging Growth Virtual Equity Conference
GlobeNewswire
·
May 28, 2025
BOTHELL, Wash., May 28, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that management will participate in a fireside chat during the Noble Capital Markets’ 2025 Emerging Growth Virtual Equity …
Vaxart Answers Additional Frequently Asked Questions from Retail Investors
GlobeNewswire
·
May 28, 2025
Company Urges Stockholders to Vote FOR Reverse Stock Split Proposal by 11:59 p.m. Eastern Time on June 1, 2025 SOUTH SAN FRANCISCO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the “Company” OR “Vaxart”) today answers additional …
Prime Announces Selection of Ausenco to Lead PEA Study Work
GlobeNewswire
·
May 28, 2025
Preliminary Economic Assessment Targeted for Completion in Q3/2025 [with Clarification of Current Drilling Status] VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Prime Mining Corp. (“Prime” or the “Company”) (TSX: PRYM) (OTCQX: PRMNF) ( …
Major Drilling to Release Results for its Fourth Quarter and Fiscal 2025 on June 11, 2025
GlobeNewswire
·
May 28, 2025
MONCTON, New Brunswick, May 28, 2025 (GLOBE NEWSWIRE) -- Major Drilling Group International Inc. (TSX: MDI) (the “Company”) will release its fourth quarter and fiscal 2025 results for the year ended April 30, 2025, on Wednesday, June 11, 2025 after the …
Agios to Present at Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025
GlobeNewswire
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced that its management team is scheduled …
Entrada Therapeutics Receives Authorization in the European Union to Initiate ELEVATE-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-45 in Patients Living with Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping
GlobeNewswire
·
May 28, 2025
– Company on track to begin ELEVATE-45-201 in Q3 2025 – – Follows recently received Medicines and Healthcare Products Regulatory Agency authorization in the United Kingdom for ELEVATE-45-201 – BOSTON, May 28, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, …
Harfang intercepte 4,5 g/t Au sur 15,6 m et délimite un nouvel axe minéralisé à haute teneur à Sky Lake, Ontario
GlobeNewswire
·
May 28, 2025
MONTRÉAL, 28 mai 2025 (GLOBE NEWSWIRE) -- Harfang Exploration Inc. (TSX.V: HAR) (« Harfang » ou la « Société ») a le plaisir d’annoncer des intersections aurifères additionnelles à haute teneur ainsi que les derniers résultats de son programme inaugural de …
Harfang Intersects 4.5 g/t Au Over 15.6 m and Delineates New High-Grade Mineralized Shoot at Sky Lake, Ontario
GlobeNewswire
·
May 28, 2025
MONTREAL, May 28, 2025 (GLOBE NEWSWIRE) -- Harfang Exploration Inc. (TSX.V: HAR) (“Harfang” or the “Company”) is pleased to announce additional high-grade intercepts and the second batch of results from the 2025 winter diamond drill program (“Winter …
Ocular Therapeutix™ To Close Enrollment This Week for SOL-R, its Second Registrational Trial Evaluating AXPAXLI™ in Wet Age-Related Macular Degeneration
GlobeNewswire
·
May 28, 2025
Enrollment for SOL-R, the largest retinal TKI trial to date, supports randomization of at least 555 subjects SOL-1, Ocular’s first registrational trial in wet AMD, completed randomization in December 2024 and retention remains exceptional as the trial …
BPGbio Presents Advances in Spatial Omics Technology and Targeted Protein Degradation Insights at ASMS 2025
GlobeNewswire
·
May 28, 2025
BOSTON, May 28, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered clinical-stage biopharma company, today announced that the company will present groundbreaking research across five sessions at the 72nd American Society for Mass …
Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split
GlobeNewswire
·
May 28, 2025
SARASOTA, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotech company advancing innovative treatments for brain-related health conditions, today announced that its Board of Directors (the “ …
Leading Global Manufacturer Requests HPQ’s First Batch of Fumed Silica for Evaluation
GlobeNewswire
·
May 28, 2025
MONTREAL, May 28, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in advanced materials and critical process development, is pleased to inform shareholders …
Un fabricant de premier plan a demandé un lot de silice pyrogénée issu du plus récent essai de HPQ, à des fins d’évaluation
GlobeNewswire
·
May 28, 2025
MONTRÉAL, 28 mai 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique spécialisée dans l’innovation en matériaux avancés et dans la mise au point de procédés critiques …
Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee
GlobeNewswire
·
May 28, 2025
If approved, tebipenem HBr could be the first oral carbapenem antibiotic for US patients with complicated urinary tract infections (cUTIs) An estimated 2.9 million cases of cUTIs are treated annually in the US1 with many cases requiring hospitalization, …
Generation Bio to Present at the 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and …
Y-mAbs Hosts Virtual Radiopharmaceutical R&D Update Highlighting Clinical Progress and Expanded Pipeline
GlobeNewswire
·
May 28, 2025
Company’s Part A data readout from first-in-human Phase 1 Trial 1001 in patients with recurrent or refractory metastatic solid tumors known to express GD2, validates GD2-SADA as safe, tolerable and able to achieve targeted in vivo conjugation of 177Lu-DOTA …
Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone
GlobeNewswire
·
May 28, 2025
--Phase 2b QUALITY clinical study topline safety data shows that the enobosarm + semaglutide combination had a positive safety profile compared to semaglutide alone-- --Based on Phase 2b QUALITY trial efficacy and safety data, enobosarm 3mg will advance as …
Goliath Mobilizes For Its Largest Drill Program Of 40,000 Meters With 9 Rigs On The Extensive Surebet High-Grade Gold Discovery That Remains Wide Open Golddigger Property, Golden Triangle, B.C.
GlobeNewswire
·
May 28, 2025
Goliath is embarking on its largest drill program to date that is 100% focused on the extensive Surebet high-grade gold discovery totaling 40,000 meters with 9 rigs based on the positive results from the 2024 drill season which has greatly improved the …
Bitget Wallet Introduces Binance Alpha Earn Zone to Maximize Liquidity Rewards
GlobeNewswire
·
May 28, 2025
SAN SALVADOR, El Salvador, May 28, 2025 (GLOBE NEWSWIRE) -- Bitget Wallet, the leading non-custodial crypto wallet, has launched the Binance Alpha Earn Zone, giving users the ability to provide liquidity to selected token pairs and earn a share of trading …